Detailansicht

Wissensnetz

Person

Markus Philipp Radsak (1973-)

Name	Markus Philipp Radsak
Zeit	1973- (Lebensdaten)
Ort	Deutschland
Akademischer Grad bzw. Titel	Dr. med. (Medizinische Fakultät an der Universität Heidelberg) (2000) Prof. (Fachbereich Medizin an der Universität Mainz)
Variante	Markus P. Radsak Markus Radsak
Datensatztyp	Person
GND-Nummer	122217713
Datensatz-ID	122217713
Beteiligt an alle anzeigen Immunomodulation of neutrophil granulocyte functions by bacterial polyphosphates A study on the effects of calreticulin del52 mutation on neutrophil adhesion : Results from CALRdel52 knock-in mice and characterization of a novel CALRdel52 Catchup mouse model Dithranol as novel co-adjuvant for non-invasive dermal vaccination Physical activity specifically evokes release of cell-free DNA from granulocytes thereby affecting liquid biopsy P1055: Clinical and genetic results of the phase IB/II TRIAL MPNSG-0212: ruxolitinib plus pomalidomide in myelofibrosis with anemia Physical activity specifically evokes release of cell-free DNA from granulocytes thereby affecting liquid biopsy ERK3/MAPK6 controls IL-8 production and chemotaxis Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice Author Correction: ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis Immunmodulation durch Toll-like-Rezeptoren : Auf dem Weg zu einer neuen Tumortherapie? Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection MHC-Klasse-II-Expression durch polymorphkernige Neutrophile : akzessorische Zellen zur Aktivierung von T-Zellen

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Markus Philipp Radsak (1973-)

Immunomodulation of neutrophil granulocyte functions by bacterial polyphosphates

A study on the effects of calreticulin del52 mutation on neutrophil adhesion : Results from CALRdel52 knock-in mice and characterization of a novel CALRdel52 Catchup mouse model

Dithranol as novel co-adjuvant for non-invasive dermal vaccination

Physical activity specifically evokes release of cell-free DNA from granulocytes thereby affecting liquid biopsy

P1055: Clinical and genetic results of the phase IB/II TRIAL MPNSG-0212: ruxolitinib plus pomalidomide in myelofibrosis with anemia

Physical activity specifically evokes release of cell-free DNA from granulocytes thereby affecting liquid biopsy

ERK3/MAPK6 controls IL-8 production and chemotaxis

Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice

Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice

Author Correction: ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial

Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses

ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis

Immunmodulation durch Toll-like-Rezeptoren : Auf dem Weg zu einer neuen Tumortherapie?

Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection

MHC-Klasse-II-Expression durch polymorphkernige Neutrophile : akzessorische Zellen zur Aktivierung von T-Zellen